Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)

(2012) Yoshiki Nishizawa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study

(2011) Toshio Matsumoto et al.   BONE

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) – 02

(2011) Hajime Orimo et al.   CURRENT MEDICAL RESEARCH AND OPINION

A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis

(2009) Hiroshi Hagino et al.   BONE

Age-related distribution of bone and skeletal parameters in 1,322 Japanese young women

(2009) Seiya Orito et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study

(2009) Noriko Yoshimura et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends

(2009) Hajime Orimo et al.   Archives of Osteoporosis

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

(2008) T. Matsumoto et al.   OSTEOPOROSIS INTERNATIONAL